Paliperidone Tablet, Extended Release
Product Images NDC 43975-352

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 43975-352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
This is a bottle of paliperidone extended-release tablets, containing 30 tablets with a dosage of 15mg of paliperidone USP each. Tablets should be swallowed whole and not divided, crushed or chewed. They should be taken once daily, and the full prescribing information can be found in the package insert. The tablets should be stored in a tight container at 20° to 25°C (68° to 77°F) and protected from moisture. The manufacturer is Inventia Healthcare Limited in India, and they are distributed by ANIPharmaceuticals, Inc. in Baudette, MN. The bottle should be kept out of reach of children.*
FDA Label Image

Image 02

Image 02
Paliperidone extended-release tablets are a prescription medication that comes in 3 mg strength. The tablets should be taken once a day, swallowed whole, and not divided, crushed, or chewed. Each tablet contains Paliperidone USP. It is important to see the package insert for complete instructions on how to take this medication. These tablets must be stored at a temperature range of 20° to 25°C (68° to 77°F) in a tightly closed container protected from moisture. They should also be kept out of reach of children. This medication is manufactured by Inventia Healthcare Limited in India and distributed by ANIPharmaceuticals, Inc. in the USA.*
FDA Label Image

Image 03

Image 03
This is a description of a medication named Paliperidone. The medication is available in the form of extended-release tablets with 6mg Paliperidone USP per tablet. The tablets are not to be chewed, divided or crushed and should be taken whole, once a day. The medicine should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F) and protected from moisture. The package insert contains the full prescribing information about the medicine's dosage. The medication is manufactured by Inventia Healthcare Limited, Ambernath, India, and distributed by ANI Pharmaceuticals, Inc., Baudette MN.*
FDA Label Image

Image 04

Image 04
This text describes a medication called Paliperidone with dosage information and storage instructions for its extended-release tablets. It advises not to divide, crush or chew the tablets and to take them once daily as directed by the package insert. The manufacturer and distributor information is also provided along with a code number for tracking purposes.*
FDA Label Image

Image 05

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.